Gentle Care Lifescience Private Limited
About Gentle Care Lifescience Private Limited
Data last updated:
Gentle Care Lifescience Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 07 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2011PTC215327. Its GSTIN is 09AAECG1602K1ZR (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vimal Kumar Giri and Mool Chand Giri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 168/169 Dda Colony Khayala, Delhi, India – 110018.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.33 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹2,119 (net margin 0.4%) and EBITDA of ₹2,864 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gentle Care Lifescience Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 168/169 Dda Colony Khayala, Delhi, India – 110018
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Gentle Care Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gentle Care Lifescience is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Gentle Care Lifescience Private Limited, buy the company report.
Financials of Gentle Care Lifescience Private Limited
FY 2025 filings availableGentle Care Lifescience Private Limited reported revenue of ₹5.33 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,864 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,119 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gentle Care Lifescience Private Limited, buy the company report.
Board of directors of Gentle Care Lifescience Private Limited
Gentle Care Lifescience has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vimal Kumar Giri | Director | 07 Mar 2011 | 15 Years 7 Months | Current |
| Mool Chand Giri | Additional Director | 16 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Gentle Care Lifescience Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jorak Life Science (OPC) Private Limited | ₹5.7 Lakh (FY 2025) | Nagpur, Maharashtra, India | ||||
| Nakoda Health Solution Private Limited | ₹5.69 Lakh (FY 2025) | Mehkar, Maharashtra, India | ||||
| Herbalbyte Solutions (OPC) Private Limited | ₹5.62 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| Humanglow Pharma Private Limited | ₹5.44 Lakh (FY 2024) | Nalagarh, Himachal Pradesh, India | ||||
| Ayonix Pharmaceutical Private Limited | ₹5.4 Lakh (FY 2025) | 548.0% | Aurangabad, Maharashtra, India | |||
| Gentle Care Lifescience Private Limitedthis company | ₹5.33 Lakh (FY 2025) | ₹2,119 | 0.4% | -12.0% | Delhi, India | |
| Jivanam Pharma Private Limited | ₹5.3 Lakh (FY 2025) | 128.0% | Panchkula, Haryana, India | |||
| Binay and Sons Pharmaceutical Industries Private Limited | ₹5.27 Lakh (FY 2024) | Ranchi, Jharkhand, India | ||||
| Medocfine Pharmaceutical Private Limited | ₹5.24 Lakh (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Lunix Pharma India Private Limited | ₹5.15 Lakh (FY 2024) | Bengaluru, Karnataka, India | ||||
| Waaqa Healthcare Private Limited | ₹4.98 Lakh (FY 2024) | Gmc, Assam, India |
To see the full peer comparison of Gentle Care Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gentle Care Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gentle Care Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gentle Care Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECG1602K1ZR | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gentle Care Lifescience Private Limited, buy the company report.
Recent activity
Gentle Care Lifescience Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Mool Chand Giri was appointed as Additional Director on 16 May 2016.
Frequently asked questions
Gentle Care Lifescience is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 07 March 2011 (15+ years old) and is registered under CIN U51909DL2011PTC215327.
Gentle Care Lifescience has 2 current directors:
- Vimal Kumar Giri - Director
- Mool Chand Giri - Additional Director
The latest financial statements of Gentle Care Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gentle Care Lifescience is 09AAECG1602K1ZR, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Gentle Care Lifescience is U51909DL2011PTC215327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gentle Care Lifescience was incorporated on 07 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Gentle Care Lifescience by revenue are Jorak Life Science (OPC) Private Limited, Nakoda Health Solution Private Limited, Herbalbyte Solutions (OPC) Private Limited, Humanglow Pharma Private Limited, Ayonix Pharmaceutical Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Mool Chand Giri was appointed as Additional Director on 16 May 2016. Pradeep Kumar Tyagi ceased to be Director on 16 May 2016. Tapan Bhardwaj ceased to be Director on 01 Jun 2013. Gentle Care Lifescience has 4 board changes on record in total.
The registered office of Gentle Care Lifescience is at C – 168169 Dda Colony Khayala, Delhi, India – 110018.
Gentle Care Lifescience operates in the trading industry, in the other wholesale segment.
The compliance status of Gentle Care Lifescience is compliant as of 22 July 2026. The company is actively filing with the Registrar of Companies.